A comparative study in morphometric grading of transitional cell carcinoma of the urinary bladder.
To overcome the considerable observer inconsistency in the histologic grading of transitional cell carcinomas, the value of four different morphometric grading methods was investigated in 61 tumors of the bladder. Only two methods showed satisfactory reproducibility. Both methods, one based on random nuclear sampling and the other on selective nuclear sampling, showed an increase in the mean and standard deviation of the nuclear area with higher tumor grades (P less than .00001). Morphometric classification of the learning set (44 cases) was in agreement with the unequivocally assessed histologic grade in 35 cases (79.5%) using random sampling and in 38 cases (86.4%) using selective sampling. By reducing the grading classes to "low" (grades 1 and 2) and "high" (grade 3) and by introducing a classification probability threshold (0.80), an accurate morphometric classification was achieved in 38 cases (86.4%) using random sampling and in 41 cases (93.2%) using selective sampling. Of the 17 cases with histologic grading discrepancies, all 10 low-grade tumors (with discrepancies of grade 1 versus grade 2) were correctly classified as low-grade carcinomas by both of the morphometric methods; in the remaining 7 cases, with low-versus-high discrepancies (grade 2 versus grade 3), the selective method yielded better correlation with the tumor stage and clinical follow-up. It is concluded that morphometric classification is an acceptable alternative for histologic grading by pathologists, provided that the reproducibility of the method is confirmed. Although both random and selective sampling yielded satisfactory classifications, the selective method gave more reliable results as confirmed by the clinical behavior.
Blomjous
C E
CE
Department of Pathology, Free University Hospital, Amsterdam, the Netherlands.
Smeulders
A W
AW
Baak
J P
JP
Vos
W
W
van Galen
C M
CM
Meijer
C J
CJ
D002295:Carcinoma, Transitional Cell / Q000473:pathology*; D002467:Cell Nucleus / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D001749:Urinary Bladder Neoplasms / Q000473:pathology*